WeedMD Posts Open Letter to Shareholders
The Shareholder Letter was cascaded earlier today and can be found on WeedMD’s website here.
Read More
Category: US Stocks
WeedMD Reports Third Quarter 2019 Financial Results and Announces Strategic Combination with Starseed
WeedMD Inc. reports net revenues of $6.7 million with a gross margin of 29%. Greenhouse cultivation cost improves to $0.72/gram in Q3.
Read More
WeedMD Announces Strategic Combination with Starseed Holdings Inc. and Secures $25 Million Cornerstone Investment
WeedMD’s leading cultivation and processing capabilities to provide consistent, high-quality supply for Starseed’s unique sales platform of captive cannabis-insured medical patients.
Read More
KALY – Kali-Extracts Anticipates Reaching $1 Million In 2019 Revenue With Q4 Hemp Extraction Contribution
KALY’s current revenues come primarily from the sale of CBD infused products that have utilized KALY’s U.S. Patented Cannabis Extraction Process.
Read More
PURA – Puration Now Has Distribution On Three Continents With Fourth To Follow Soon
PURA recently closed an acquisition to enable PURA to bottle CBD Beverages in Europe for the European market.Â
Read MoreGET LISTED
